title: Intranasal administration of nerve growth factor (NGF) rescues recognition memory deficits in AD11 anti-NGF transgenic mice.
abstract: Nerve growth factor (NGF) delivery to the brain of patients appears to be an emerging potential therapeutic approach to neurodegenerative disease, such as Alzheimer's disease (AD). The intranasal route of administration could provide an alternative to intracere-broventricular infusion and gene therapy. We previously showed that intranasal administration of NGF determined an amelioration of cholinergic deficit and a decrease in the number of phosphotau-positive neurons and of beta-amyloid accumulation in AD11 mice, which express transgenic antibodies neutralizing NGF action and exhibit a progressive Alzheimer-like neurodegeneration. In this study, we report that the Alzheimer-like neurodegeneration in AD11 mice is linked to progressive behavioral deficits in visual recognition memory and spatial memory starting from 4 months of age. To establish whether intranasal administration of NGF, started after the appearance of the first memory deficits, could revert the cognitive deficits in AD11 mice, we assessed the performance of NGF-treated or control AD11 mice in the object recognition test and in a test of memory for place and context. Deficits exhibited by untreated AD11 mice could be rescued by the intranasal administration of NGF. Thus, this route of administration provides a promising way to deliver NGF to the brain in a therapeutic perspective.
authors.affiliation: Lay Line Genomics S.p.A., Via di Castel Romano 100, 00128 Rome, Italy.
authors.forename: Roberta
authors.initials: R
authors.lastname: De Rosa
authors.forename: Addys Ancheta
authors.initials: AA
authors.lastname: Garcia
authors.forename: Chiara
authors.initials: C
authors.lastname: Braschi
authors.forename: Simona
authors.initials: S
authors.lastname: Capsoni
authors.forename: Lamberto
authors.initials: L
authors.lastname: Maffei
authors.forename: Nicoletta
authors.initials: N
authors.lastname: Berardi
authors.forename: Antonino
authors.initials: A
authors.lastname: Cattaneo
mesh_terms: D000281:Administration, Intranasal; D000544:Alzheimer Disease / Q000188:drug therapy* / Q000523:psychology; D000818:Animals; D004195:Disease Models, Animal; D018450:Disease Progression; D008569:Memory Disorders / Q000188:drug therapy*; D051379:Mice; D008822:Mice, Transgenic; D020932:Nerve Growth Factor / Q000008:administration & dosage*
chemical_list: D020932:Nerve Growth Factor
references.citation: Behav Brain Res. 1988 Nov 1;31(1):47-59
references.pmid: 3228475
references.citation: Dement Geriatr Cogn Disord. 1998 Sep-Oct;9(5):246-57
references.pmid: 9701676
references.citation: Curr Opin Neurobiol. 2001 Apr;11(2):188-93
references.pmid: 11301238
references.citation: Psychoneuroendocrinology. 2004 Nov;29(10):1326-34
references.pmid: 15288712
references.citation: J Neurosci. 1994 Aug;14(8):4815-24
references.pmid: 8046452
references.citation: Gene Ther. 1996 Apr;3(4):305-14
references.pmid: 8732162
references.citation: Ann N Y Acad Sci. 1993 Sep 24;695:292-9
references.pmid: 8239298
references.citation: Mol Cell Neurosci. 2002 Sep;21(1):15-28
references.pmid: 12359148
references.citation: Ann N Y Acad Sci. 1952 Aug 8;55(2):330-44
references.pmid: 12977049
references.citation: Clin Pharmacokinet. 2001;40(12):907-46
references.pmid: 11735609
references.citation: Science. 1987 Sep 4;237(4819):1154-62
references.pmid: 3306916
references.citation: Prog Brain Res. 2004;146:441-9
references.pmid: 14699979
references.citation: J Neurosci. 1996 May 15;16(10):3541-8
references.pmid: 8627387
references.citation: Exp Neurol. 1998 Dec;154(2):573-82
references.pmid: 9878192
references.citation: Learn Mem. 2002 Mar-Apr;9(2):49-57
references.pmid: 11992015
references.citation: J Neurosci. 2004 Jun 30;24(26):5901-8
references.pmid: 15229237
references.citation: Hippocampus. 1991 Jan;1(1):1-8
references.pmid: 1669339
references.citation: Ann Neurol. 1991 Nov;30(5):625-36
references.pmid: 1763889
references.citation: J Neurosci. 2000 Apr 1;20(7):2589-601
references.pmid: 10729339
references.citation: Proc Natl Acad Sci U S A. 2000 Jun 6;97(12):6826-31
references.pmid: 10841577
references.citation: Behav Brain Res. 1999 Mar;99(2):191-200
references.pmid: 10512585
references.citation: Proc Natl Acad Sci U S A. 1994 Nov 8;91(23):10898-902
references.pmid: 7971980
references.citation: Prog Neurobiol. 2002 Oct;68(3):209-45
references.pmid: 12450488
references.citation: Proc Natl Acad Sci U S A. 2002 Sep 17;99(19):12432-7
references.pmid: 12205295
references.citation: Neurology. 2004 Apr 27;62(8):1317-22
references.pmid: 15111668
references.citation: Brain Res. 1984 Feb 20;293(2):305-11
references.pmid: 6697222
references.citation: Nature. 1987 Sep 3-9;329(6134):65-8
references.pmid: 3627243
references.citation: Eur J Neurosci. 2002 Mar;15(6):1030-6
references.pmid: 11918663
references.citation: J Alzheimers Dis. 1998 Mar;1(1):35-44
references.pmid: 12214010
references.citation: Neuroscience. 2004;127(2):481-96
references.pmid: 15262337